
Health insurance company UnitedHealth (NYSE:UNH) will be reporting results this Tuesday before market hours. Here’s what to expect.
UnitedHealth beat analysts’ revenue expectations last quarter, reporting revenues of $112 billion, flat year on year. It was a very strong quarter for the company, with a beat of analysts’ EPS estimates.
Is UnitedHealth a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.
This quarter, the market is expecting UnitedHealth’s revenue to decline 1.6% year on year, a reversal from the 12.2% increase it recorded in the same quarter last year.
Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business will stay the course heading into earnings. UnitedHealth has missed Wall Street’s revenue estimates multiple times over the last two years.
With UnitedHealth being the first among its peers to report earnings this season, we don’t have anywhere else to look to get a hint at how this quarter will unfold for healthcare providers & services stocks. However, investors in the segment have had steady hands going into earnings, with share prices up 1.9% on average over the last month. UnitedHealth’s stock price was unchanged during the same time .
ALSO WORTH WATCHING: Nvidia’s Quiet Partner. Nvidia’s chips cost a hundred grand. The connectors that make them work cost even more. One company makes them all.
Every AI server needs specialized infrastructure the chip companies don’t make. High-speed cables. Power connectors. Thermal sensors. This 90-year-old company built a monopoly on it. The AI boom just started. This stock is still flying under the radar. Claim The Stock Ticker Here for FREE.